株式会社FerroptoCure
Tokyo, JP · 3 known investors
Find your way into 株式会社FerroptoCure
Sign up to see every warm intro you have to 株式会社FerroptoCure
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社FerroptoCure team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FerroptoCure is a drug development company targeting ferroptosis pathways for therapeutic applications. The company focuses on advancing pharmaceutical candidates through clinical development stages in Japan and internationally.
Founders & leadership
大
大槻雄士代表取締役CEO 共同創業者
佐
佐谷秀行共同創業者
永
永野修共同創業者
夏
夏目徹共同創業者
西
西山伸宏共同創業者
YO
Yushi OtsukiRepresentative Director CEO
Investors · 3
Frequently asked questions
- What does 株式会社FerroptoCure do?
- FerroptoCure is a drug development company targeting ferroptosis pathways for therapeutic applications. The company focuses on advancing pharmaceutical candidates through clinical development stages in Japan and internationally.
- Who founded 株式会社FerroptoCure?
- 株式会社FerroptoCure was founded by 大槻雄士, 佐谷秀行, 永野修, 夏目徹, 西山伸宏.
- Who are 株式会社FerroptoCure's investors?
- 株式会社FerroptoCure's investors include MIRAI SOUZOU, Tokyo University of Science Innovation Capital, Vision Incubate.
- Where is 株式会社FerroptoCure headquartered?
- 株式会社FerroptoCure is headquartered in Tokyo, JP.